Go Pro

Avalyn Pharma (AVLN) Institutional Ownership

Avalyn Pharma logo
$38.37 +1.24 (+3.34%)
As of 08/21/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Avalyn Pharma (NASDAQ:AVLN)

Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$110.11M
Number of
Institutional Sellers
(last 12 months)
0
Get AVLN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avalyn Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Avalyn Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/21/2026 Braidwell LP801,395$26.38M1.0%N/A1.808%
8/20/2026 Montanova Capital LLC2,503,109$82.40M1.4%N/A5.646%
8/6/2026 Bank of New York Mellon Corp40,140$1.32M0.0%N/A0.091%


AVLN Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Avalyn Pharma shares: Montanova Capital LLC ($82.40M), and Braidwell LP ($26.38M), Bank of New York Mellon Corp ($1.32M).Learn more on Avalyn Pharma's institutional investors.

The following institutional investors have purchased Avalyn Pharma's stock in the last 24 months: Montanova Capital LLC ($2.50M), Braidwell LP ($801.40K), and Bank of New York Mellon Corp ($40.14K).

Institutional investors have bought a total of 3,344,644 shares in the last 24 months. This purchase volume represents approximately $110.11M in transactions.



Institutional ownership data for NASDAQ:AVLN is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/21/2026. New 13F filings are added each quarter as they're published.
From Our Partners